Key regions: Canada, United States, Australia, Brazil, Japan
The Digestives & Intestinal Remedies market in Eastern Asia is experiencing significant growth due to changing customer preferences and increasing awareness about digestive health. Customer preferences in the Digestives & Intestinal Remedies market in Eastern Asia are shifting towards natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they consume and are seeking natural alternatives to address digestive issues. This preference for natural remedies is driving the demand for herbal and plant-based products in the market. Additionally, consumers are also looking for products that provide long-term benefits and promote overall digestive health, rather than just providing temporary relief from symptoms.One of the key trends in the Digestives & Intestinal Remedies market in Eastern Asia is the growing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestion and overall gut health. They are commonly found in fermented foods and supplements. The increasing awareness about the importance of gut health and the role of probiotics in maintaining a healthy digestive system has led to a surge in demand for probiotic products. This trend is expected to continue in the coming years as consumers become more educated about the benefits of probiotics.Another trend in the market is the rising demand for digestive enzymes. Digestive enzymes are substances that help break down food into smaller molecules for better absorption and digestion. They are often used to alleviate symptoms of digestive disorders such as bloating, gas, and indigestion. The increasing prevalence of digestive disorders in the region, coupled with the growing awareness about digestive enzymes, is driving the demand for these products.In addition to changing customer preferences, there are also local special circumstances that are contributing to the growth of the Digestives & Intestinal Remedies market in Eastern Asia. One such circumstance is the aging population in countries like Japan and South Korea. As the population ages, there is a higher incidence of digestive disorders and a greater need for digestive health products. This demographic shift is creating a significant market opportunity for companies operating in the Digestives & Intestinal Remedies sector.Furthermore, the increasing urbanization and hectic lifestyles in Eastern Asia have led to changes in dietary habits, including a rise in processed and unhealthy food consumption. This has resulted in a higher prevalence of digestive issues among the population, further driving the demand for Digestives & Intestinal Remedies products.Underlying macroeconomic factors such as rising disposable incomes and improving healthcare infrastructure are also contributing to the growth of the market. As incomes rise, consumers are willing to spend more on healthcare products, including those related to digestive health. Moreover, the availability of a wide range of products and the expansion of distribution channels are making Digestives & Intestinal Remedies more accessible to consumers in Eastern Asia.Overall, the Digestives & Intestinal Remedies market in Eastern Asia is witnessing growth due to changing customer preferences, increasing awareness about digestive health, local special circumstances, and underlying macroeconomic factors. The market is expected to continue expanding as consumers prioritize their digestive health and seek natural and effective remedies.
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
